In a discussion moderated by Peter Salgo, MD, panelists Jeffrey Weber, MD, PhD, Michael Kolodziej, MD, and Daniel J. George, MD, share their insights and perspectives about cancer immunotherapy in the managed care setting.
Dr Salgo opens up the discussion with some facts about cancer and claims that cancer is currently recognized as the “global pandemic” that killed more than 600,000 US persons in 2012 alone. Despite its deep history, the potential of cancer immunotherapy has only been tapped into recently. Due to the high costs of treatment, cancer immunotherapy is debatable. Dr Salgo explains that a majority of the immunotherapy drugs approved by the US Food and Drug Administration cost over $100,000 per year.
Regardless of these costs, Dr George believes we need to take advantage of this therapy option, as it has proved more effective than standard therapy options such as chemotherapy and radiation when treating several types of cancer.
Dr George continues the discussion with an explanation about how cancer immunotherapy works. Dr Weber concludes by defining immunotherapy as a “targeted therapy,” and cites Provenge, a targeted therapy cancer vaccine, as an example.
Health Equity and Access Weekly Roundup: May 4, 2024
May 4th 2024This week, the Center on Health Equity and Access highlights a variety of gaps that exist in health care, spanning women's health, the rising rate of metabolic disease, and policy for LGBTQ+ and immigrant populations. The consensus among featured experts points to comprehensive care models.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More